New nanoparticles wait to release drugs, target infection – Researchers from Washington State University

Current WSU research shows stimuli-responsive nanoparticles can specifically target infections to simultaneously prevent the spread of bacteria and reduce the inflammation it causes. These microscopic particles are loaded with antibiotic and anti-inflammatory agents which are released when the particles encounter infection in the body. Researchers in the lab of Pharmaceutical Sciences Assistant Professor Zhenjia Wang

Continue Reading

New study conducted by USCF maps the links between 625 genes and various different chemotherapy treatments

Despite successes of targeted cancer drugs and the promise of novel immunotherapies, the vast majority of people diagnosed with cancer are treated with chemotherapy. Now a new study by UCSF researchers using techniques drawn from computational biology could make it easier for physicians to use the patient’s genetic profile of the tumour to pick the

Continue Reading

Research team at Vanderbilt University discover ionising radiation can soften tumour cell microenvironment

Approximately half of all cancer patients receive radiation therapy to reduce the growth of malignant cells. However, little is known about how ionising radiation affects the extracellular matrix (ECM), a patchwork of proteins and other biomolecules that surrounds cells and plays a vital role in their shape, movement and signalling functions. A team of researchers

Continue Reading

3-D printed models created by Stanford School of Medicine that will improve medical student training

According to a study presented at the Society of Interventional Radiology’s 2018 Annual Scientific Meeting , an inexpensive 3-D-printed model of a patient’s blood vessels is as effective as current commercially available models for training medical students in interventional radiology vascular access. “We’ve come up with a viable method for creating something that’s inexpensive and

Continue Reading

UK based developer gains investment for world’s first portable fingerprint drug test

UK-based Intelligent Fingerprinting, have secured £1.7 million of funding from a group of private US and UK investors for the world’s first portable fingerprint drug test. The investment will allow for accelerated commercialisation of the recently launched Intelligent Fingerprinting Drug Screening System. Particularly into key UK workplace market sectors such as construction, transport, warehousing and

Continue Reading